Tue, Aug 20 2:44pm

Repligen Corp [RGEN]
$92.07 1.54 (1.64%)

RGEN Profile

Sector Health Care
Industry Biotech & Pharma
Market Cap 4.77 Billion
RGEN Description

Repligen Corp is a bioprocessing company that develops, produces and commercializes innovative biologic drugs. The company's customers include life science companies, global biopharmaceutical companies, and contract manufacturers worldwide. Repligen markets its products globally through a direct commercial organization in the U.S., Europe, and Asia, as well as through strategic partners in select markets. The majority of the company's revenue is generated in the United States.

Visit Website

RGEN Earnings

EPS 0.17 P/E Ratio 119.64
Previous Earnings Fri, Apr 26, 2019
Latest Earnings Thu, Aug 1, 2019 (19 days ago) -2.09%

RGEN Dividend

Yield --
Ex-Date --
Pay Date --
History --

RGEN Charts

1 Year
Dec 24, 2018
Aug 1, 2019

Symbol Price Day % YTD %
RGEN $92.07 -1.64% 78.22%

Symbol Surfing

How can we make Symbol Surfing better?


Information is provided "as is" and solely for informational purposes, not for trading purposes or advice, and may be delayed.

©2019 Symbol Surfing All Rights Reserved.

Cookies Policy | Terms Of Service | Privacy Policy